Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Budesonide MMX Is Effective in Patients Having Persistent Symptoms and Raised Fecal Calprotectin Following Treatments for Diverticular DiseaseAntonio Tursi, Claudio Cassieri, Raffaele Colucci, et al.Annals of Gastroenterology|March 3, 2021
The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up studyAntonio Tursi, Marilisa Franceschi, Walter Elisei, et al.Journal of Clinical Gastroenterology|September 14, 2016
Management of Patients With Diverticulosis and Diverticular Disease: Consensus Statements From the 2nd International Symposium on Diverticular DiseaseAntonio Tursi, Marcello Picchio, Walter Elisei, et al.Journal of Clinical Gastroenterology|September 14, 2016
Current Management of Patients With Diverticulosis and Diverticular Disease: A Survey From the 2nd International Symposium on Diverticular DiseaseAntonio Tursi, Marcello Picchio, Walter Elisei, et al.Hepato-Gastroenterology|June 28, 2013
factors influencing mucosal healing in Crohn's disease during infliximab treatmentAntonio Tursi, Walter Elisei, Gian Marco Giorgetti, et al.Journal of Clinical Gastroenterology|September 14, 2016
Prognostic Role of the Endoscopic Classification "DICA"Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.European Journal of Gastroenterology & Hepatology|April 19, 2021
The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort studyAntonio Tursi, Walter Elisei, Marilisa Franceschi, et al.Minerva Gastroenterology|February 19, 2026
The SymbioCare initiative: management of irritable bowel syndrome, comparison between Italian gastroenterologists and general practitionersPaolo Usai Satta, Marco Astegiano, Andrea Pasta, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 30, 2007
Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infectionAntonio Tursi, Walter Elisei, Giovanni Brandimarte, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 28, 2004
Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitisAntonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti, et al.Pageof 10